Menora Mivtachim Holdings’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-21,939
Closed -$699K 85
2017
Q2
$699K Hold
21,939
0.03% 65
2017
Q1
$712K Sell
21,939
-671,521
-97% -$21.2M 0.04% 61
2016
Q4
$21.4M Sell
693,460
-131,329
-16% -$4.01M 1.1% 33
2016
Q3
$26.5M Sell
824,789
-301,444
-27% -$10.1M 1.46% 24
2016
Q2
$37.6M Hold
1,126,233
2.13% 18
2016
Q1
$31.7M Hold
1,126,233
1.9% 23
2015
Q4
$34.5M Hold
1,126,233
2.2% 19
2015
Q3
$33.6M Buy
1,126,233
+171,275
+18% +$5.49M 2.5% 17
2015
Q2
$30.4M Buy
954,958
+1,634
+0.2% +$53.3K 2.31% 16
2015
Q1
$31.5M Hold
953,324
2.54% 17
2014
Q4
$28.2M Sell
953,324
-124,372
-12% -$3.57M 2.47% 18
2014
Q3
$30.2M Buy
1,077,696
+55,936
+5% +$1.57M 2.08% 21
2014
Q2
$28.8M Buy
1,021,760
+105,400
+12% +$3M 2.3% 20
2014
Q1
$27.9M Sell
916,360
-63,149
-6% -$1.88M 2.29% 20
2013
Q4
$28.5M Hold
979,509
2.5% 16
2013
Q3
$26.7M Buy
979,509
+130,696
+15% +$3.56M 2.44% 18
2013
Q2
$22.6M Buy
+848,813
New +$23.5M 1.92% 22

Other funds holding PFE

Menora Mivtachim Holdings's PFE Position: Q3 2017 in Review

Menora Mivtachim Holdings sold out of Pfizer (PFE) in Q3 2017, closing a stake of 21,939 shares — an estimated $699K sold.

Menora Mivtachim Holdings first reported a position in PFE in Q2 2013 and held it in 17 quarters. The position peaked at $37.6M in Q2 2016. 2,042 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

  • Menora Mivtachim Holdings reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
  • Menora Mivtachim Holdings sold 21,939 Pfizer shares in Q3 2017, an estimated $699K.
  • Menora Mivtachim Holdings first reported a position in Pfizer in Q2 2013 and held it in 17 quarters.
  • Menora Mivtachim Holdings's Pfizer position peaked at $37.6M in Q2 2016.
  • 2,042 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Menora Mivtachim Holdings's 13F filing for Q3 2017, filed 30 Oct 2017.